Patents
Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
11/2009
11/24/2009US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/17/2009US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/11/2009CN100558743C Method for separating and purifying microcystin
11/05/2009WO2009000971A3 Peptide gacfsiahecga for targeting mtl-mmp
11/04/2009EP2112930A2 Modulation of nkt cell activity with antigen-loaded cdid molecules
10/2009
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/22/2009WO2009106715A3 Peptide derived from a protein of the aquaporin family
10/06/2009US7597875 Diaminedioxime radiometal complexes
09/2009
09/29/2009US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity
09/29/2009US7595052 Composition and method for the prevention and/or the treatment of allergy
09/23/2009CN101538313A Peptide-based compounds
09/23/2009CN101537190A Peptide-based compounds
09/17/2009WO2009112645A1 Peptide for activating aquaporin synthesis
09/17/2009WO2002072597A9 Helicomimetics and stabilized lxxll peptidomimetics
09/15/2009US7589174 GRP94-based compositions and methods of use thereof
09/08/2009US7585943 Peptide linker comprising thrombin cleavage site; enhancing recovery and purification of exogenously expressed polypeptides
09/03/2009WO2009106715A2 Peptide derived from a protein of the aquaporin family and cosmetic and/or pharmaceutical composition containing same
09/03/2009US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation
08/2009
08/27/2009US20090215703 PAR-2 Agonist
08/26/2009EP2091959A1 Improved peptide composition
08/25/2009US7579443 Lyases; improved ethanol biosynthesis, stalk and nodal strength
08/19/2009EP2090654A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME
08/19/2009EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna
08/12/2009CN101505782A Methods and compositions for conserving and/or preparing an organ or tissue for transplant
08/06/2009WO2009096112A1 Tag peptide and use thereof
08/06/2009WO2008106551A8 Brachyury polypeptides and methods for use
08/06/2009US20090197798 Synthetic anti-neuropilin 1 (NRP1) cyclic peptide containing RRXR motif
08/05/2009EP2007911A4 Soluble virus-specific t-cell receptor compositions
08/05/2009CN101501060A Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
08/05/2009CN100522249C Elogated and multiple spacers in activatible prodrugs
08/04/2009US7569542 can be produced recombinantly using bacterial, yeast, or eukaryotic cell expression system, without having to deal with problems associated with chemical or physical linkages
08/04/2009US7569537 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of Mycobacterium tuberculosis
07/2009
07/30/2009WO2009093962A1 Multifunctional tags
07/30/2009US20090192189 Treatment of cancers expressing p95 erbb2
07/29/2009EP1409984B1 Methods and reagents for detecting endotoxin
07/29/2009EP1401473B1 Transporters comprising spaced arginine moieties
07/28/2009US7566767 Synthetic peptides and methods of use for autoimmune disease therapies
07/28/2009US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses
07/23/2009DE102008005097A1 Herstellung und Verwendung antitumoraler Cyclodepsipeptide Production and use of anti-tumor cyclodepsipeptides
07/22/2009EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis
07/22/2009EP1501939B1 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix
07/22/2009CN101490078A Soluble virus-specific T-cell receptor compositions
07/16/2009WO2009026653A8 Neuroplasticity assay
07/16/2009US20090181894 Chimeric toxins for targeted therapy
07/15/2009EP2078529A1 Antimicrobial peptides
07/15/2009CN101481404A Zymohydrolysis lactoprotein ferrous complex compound microcapsule iron supplement agent and preparation thereof
07/08/2009EP2076276A2 Sol-gel materials for cellular modulation
07/08/2009EP2001496A4 Use of gelsolin to diagnose and treat inflammatory diseases
07/08/2009CN101475628A Enzymatic hydrolysis lactoprotein zinc complex compound and preparation thereof
07/08/2009CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate
07/07/2009US7556811 Peptide epitopes of apolipoprotein B
07/07/2009US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides
07/01/2009CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/2009
06/23/2009US7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen
06/18/2009US20090156507 Cell permeable conjugates of peptides for inhibition of protein kinases
06/16/2009US7547761 For isolating low molecular weight peptides from animal tissue; prevention of initial dissolution of higher molecular weight fraction proteins by in situ denaturation within the tissue, by an organic solvent (preferably ethanol), prior to aqueous extraction
06/11/2009WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
06/09/2009US7544772 Reducing mucin levels with myristoylated protein (MANS) or fragments; inhibiting the exocytotic release of inflammatory mediator; respiratory disorders; ulcerative colitis, Crohn's disease and irritable bowel syndrome, rosacea, eczema, psoriasis and severe acne, arthritis or cystic fibrosis
06/09/2009US7544360 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
06/09/2009US7544353 A hair-binding peptide and a hair conditioning agent
06/04/2009WO2009070786A2 Peptide and multivalent peptide conjugate for diagnosis and treatment of vascular plaques
06/04/2009WO2009022154A3 Peptide with multiple epitopes
06/02/2009US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor
05/2009
05/27/2009EP2061491A2 Methods and compositions for conserving and/or preparing an organ or tissue for transplant
05/27/2009CN101443030A Use of gelsolin to diagnose and treat inflammatory diseases
05/26/2009US7537758 Antibodies against a peptide epitope of apolipoprotein B
05/19/2009US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections
05/14/2009US20090124559 Soft Protease Inhibitors and Pro-Soft Forms Thereof
05/13/2009EP2058275A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
05/13/2009CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis
05/07/2009US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins
05/07/2009US20090118169 Novel compounds and pharmaceutical use thereof
05/05/2009US7528225 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
05/05/2009US7527947 Cultivating a fungal host cell comprising a nucleic acid construct comprising a first and second nucleotide sequence encoding a signal peptide; isolating the secreted polypeptide
05/05/2009US7527795 Peptide epitopes of apolipoprotein B
04/2009
04/30/2009WO2009052572A1 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
04/30/2009WO2006133107A3 Specific binding sites in collagen for integrins and use thereof
04/30/2009WO2006081301A3 Plant defense signal peptides
04/30/2009US20090111970 used to regulate an immune response in an animal; inhibits TF-1 cell proliferation activity
04/29/2009EP1976985A4 Methods and compositions related to mutant kunitz domain i of tfpi-2
04/29/2009EP1969369A4 Novel capture agents for binding a ligand
04/29/2009CN101418034A Method for extracting jatropha curcas seed oil protein
04/28/2009US7524933 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
04/23/2009WO2009021077A3 Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same
04/22/2009EP2049562A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
04/22/2009EP1969371A4 A method of producing a multimeric capture agent for binding a ligand
04/16/2009WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna
04/16/2009WO2005035714A3 Vaccines for cancer, autoimmune disease and infections
04/15/2009EP2046812A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide
04/15/2009EP2046363A1 Antimicrobial peptides
04/14/2009US7517655 Protein capable of deposition onto extracellular matrix
04/09/2009WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins
04/09/2009WO2006069001A3 Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands
04/08/2009EP1791857A4 Conformational switches in toxin folding and uses thereof
04/01/2009EP2042186A1 Novel polypeptide ligands for toll-like receptor 2 (TLR2)
04/01/2009CN101400787A Mass producing method of growth factor using adipose derived adult stem cells
03/2009
03/26/2009WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 22